Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

Risto Kerkelä, Luanda Grazette(Massachusetts General Hospital), Rinat Yacobi(Molecular Oncology (United States)), Cezar Iliescu(The University of Texas MD Anderson Cancer Center), Richard D. Patten(Tufts University), Cara Beahm, Brian Walters(Tufts University), Sergei Shevtsov(Tufts University), Stéphanie Pesant, Fred J. Clubb, Anthony Rosenzweig(Harvard University), Robert Salomon(Tufts Medical Center), Richard A. Van Etten(Tufts Medical Center), Joseph Alroy(New England Disabled Sports), Jean‐Bernard Durand(The University of Texas MD Anderson Cancer Center), Thomas Force(Tufts Medical Center)
Nature Medicine
July 23, 2006
10.1038/nm1446
Cited by 1,164

Abstract

Related Papers

XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription Factor
Hiderou Yoshida, Toshie Matsui, Akira Yamamoto et al.|Cell|2001|4k
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
M. Gorre, Mansoor Mohammed, Katharine Ellwood et al.|Science|2001|3.1k
Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function
Maria Ankarcrona, Jeannette M. Dypbukt, Emanuela Bonfoco et al.|Neuron|1995|1.9k
Coupling endoplasmic reticulum stress to the cell death program
Rammohan V. Rao, H. Michael Ellerby, Dale E. Bredesen|Cell Death and Differentiation|2004|1.2k
Translational control in the endoplasmic reticulum stress response
David Ron|Journal of Clinical Investigation|2002|784